Literature DB >> 23062600

Mutation analysis of PFN1 in familial amyotrophic lateral sclerosis patients.

Hussein Daoud1, Sylvia Dobrzeniecka, William Camu, Vincent Meininger, Nicolas Dupré, Patrick A Dion, Guy A Rouleau.   

Abstract

Mutations in the profilin 1 (PFN1) gene, encoding a member of the profilin family of small actin-binding proteins, have been recently reported in patients with familial amyotrophic lateral sclerosis (ALS). In this study we aimed to determine the prevalence of PFN1 mutations by sequencing the coding region of this gene in a cohort of 94 familial ALS patients from France and Quebec. No mutations were identified in our cohort suggesting that PFN1 gene mutations are a very rare cause of familial ALS among patients with predominantly European ancestry.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23062600     DOI: 10.1016/j.neurobiolaging.2012.09.001

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  18 in total

Review 1.  Amyotrophic lateral sclerosis: an update on recent genetic insights.

Authors:  Yohei Iguchi; Masahisa Katsuno; Kensuke Ikenaka; Shinsuke Ishigaki; Gen Sobue
Journal:  J Neurol       Date:  2013-10-02       Impact factor: 4.849

Review 2.  Clinical neurogenetics: amyotrophic lateral sclerosis.

Authors:  Matthew B Harms; Robert H Baloh
Journal:  Neurol Clin       Date:  2013-11       Impact factor: 3.806

Review 3.  Autophagy as a common pathway in amyotrophic lateral sclerosis.

Authors:  Dao K H Nguyen; Ravi Thombre; Jiou Wang
Journal:  Neurosci Lett       Date:  2018-04-04       Impact factor: 3.046

4.  Profilin 1 associates with stress granules and ALS-linked mutations alter stress granule dynamics.

Authors:  Matthew D Figley; Gregor Bieri; Regina-Maria Kolaitis; J Paul Taylor; Aaron D Gitler
Journal:  J Neurosci       Date:  2014-06-11       Impact factor: 6.167

5.  Intrinsic disorder in proteins involved in amyotrophic lateral sclerosis.

Authors:  Nikolas Santamaria; Marwa Alhothali; Maria Harreguy Alfonso; Leonid Breydo; Vladimir N Uversky
Journal:  Cell Mol Life Sci       Date:  2016-11-12       Impact factor: 9.261

Review 6.  Profilin1 biology and its mutation, actin(g) in disease.

Authors:  Duah Alkam; Ezra Z Feldman; Awantika Singh; Mahmoud Kiaei
Journal:  Cell Mol Life Sci       Date:  2016-09-26       Impact factor: 9.261

7.  A novel small molecule HSP90 inhibitor, NXD30001, differentially induces heat shock proteins in nervous tissue in culture and in vivo.

Authors:  Jieun R C Cha; Kyle J H St Louis; Miranda L Tradewell; Benoit J Gentil; Sandra Minotti; Zahara M Jaffer; Ruihong Chen; Allan E Rubenstein; Heather D Durham
Journal:  Cell Stress Chaperones       Date:  2013-10-03       Impact factor: 3.667

8.  PFN1 mutations are also rare in the Catalan population with amyotrophic lateral sclerosis.

Authors:  Enrique Syriani; Candi Salvans; Maria Salvadó; Miguel Morales; Laura Lorenzo; Sonia Cazorla; Josep Gamez
Journal:  J Neurol       Date:  2014-09-24       Impact factor: 4.849

Review 9.  Incorporating upper motor neuron health in ALS drug discovery.

Authors:  Ina Dervishi; P Hande Ozdinler
Journal:  Drug Discov Today       Date:  2018-01-10       Impact factor: 7.851

10.  Profilin-1 mutations are rare in patients with amyotrophic lateral sclerosis and frontotemporal dementia.

Authors:  Marka van Blitterswijk; Matthew C Baker; Kevin F Bieniek; David S Knopman; Keith A Josephs; Bradley Boeve; Richard Caselli; Zbigniew K Wszolek; Ronald Petersen; Neill R Graff-Radford; Kevin B Boylan; Dennis W Dickson; Rosa Rademakers
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2013-05-02       Impact factor: 4.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.